• Brust JCM, Lygizos M, Chaiyachati K et al. (2011) Culture conversion among HIV Co-infected multidrug- resistant tuberculosis patients in Tugela Ferry, South Africa. PLoS One 6, e15841.
  • Day C, Barron P, Massyn N, Padarath A & English R (eds) (2012) District Health Barometer 2010/11. Health Systems Trust, Durban. ISBN Number: 978-1-919839-70-7.
  • Directorate Drug- Resistant TB (2011a) Multi-Drug Resistant Tuberculosis: A Policy Framework on Decentralised and Deinstitutionalised Management for South Africa. Infection Control. Directorate Drug- Resistant TB, Pretoria.
  • Directorate Drug- Resistant TB (2011b) Management of Drug-Resistant Tuberculosis: Policy Guidelines. Health Care. Directorate Drug- Resistant TB, Pretoria.
  • Directorate Tuberculosis Control (2007) Management of Drug-resistant Tuberculosis in South Africa: Policy Guidelines. Directorate Drug- Resistant TB, Pretoria.
  • Farley JE, Ram M, Pan W et al. (2011) Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. PLoS One 6, e20436.
  • Fitzpatrick C & Floyd K (2012) A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. Pharmacoeconomics 30, 6380.
  • Floyd K (2002) Guidelines for Cost and Cost-effectiveness Analysis of Tuberculosis Control. Guidelines for Cost and Cost-effectiveness Analysis of Tuberculosis Control. WHO, Geneva. doi: WHO/CDS/TB/2002.305a.
  • Gandhi NR, Shah NS, Andrews JR et al. (2010) HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. American Journal of Respiratory and Critical Care Medicine 181, 8086.
  • Long L, Fox M, Sanne I & Rosen S (2010) The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS 24, 915919.
  • Meyer-Rath G, Schnippel K, Long L et al. (2012) The impact and cost of scaling up GeneXpert MTB/RIF in South Africa (ed. MP Nicol) PLoS One 7, e36966.
  • Oanda (2012) USD ZAR Average exchange rate 1 Jan 2011-31 Dec 2011. Historical Exchange Rates.
  • Orenstein EW, Basu S, Shah NS et al. (2009) Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. The Lancet Infectious Diseases 9, 153161.
  • Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R & Maher D (2003) Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. The International Journal of Tuberculosis and Lung Disease 7, S56S62.
  • Statistics South Africa (2012) Statistical Release: Consumer Price Index, Vol. P0141. Statistics South Africa, Pretoria.
  • Suchindran S, Brouwer ES & Van Rie A (2009) Is HIV infection a risk factor for multi-drug resistant tuberculosis? a systematic review PLoS One 4, e5561.
  • TB Control Programme (2008) South African National Tuberculosis Guidelines. South Africa National Department of Health, Pretoria.
  • WHO (2011a) Towards Universal Access to Diagnosis and Treatment of Multidrug-resistant and Extensively Drug-resistant Tuberculosis by 2015: WHO Progress Report 2011. WHO, Geneva.
  • WHO (2011b) Global Tuberculosis Control: WHO Report 2011. Tuberculosis. WHO, Geneva. doi: ISBN 978 92 4 156438 0.
  • Zignol M, Gemert WV, Falzon D et al. (2012) Surveillance of anti-tuberculosis drug resistance in the world : an updated analysis 2007 – 2010. Bulletin of the World Health Organization 90, 111119.